Elsevier

Clinical Therapeutics

Volume 21, Issue 10, October 1999, Pages 1725-1731
Clinical Therapeutics

Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians

https://doi.org/10.1016/S0149-2918(99)80051-4Get rights and content

Abstract

Family physicians, internists, and pediatricians are more likely to prescribe combination topical antifungal-topical corticosteroid preparations than are dermatologists. One such preparation, clotrimazolebetamethasone dipropionate, can cause atrophy because it has a high-potency corticosteroid component. We analyzed data from the National Ambulatory Medical Care Survey for visits to pediatricians from 1990 to 1994 and isolated visits at which a topical corticosteroid agent or clotrimazolebetamethasone dipropionate was prescribed. Pediatricians rarely prescribed single-agent, high-potency topical corticosteroid agents in managing patients with skin disorders. High-potency corticosteroid agents accounted for 5.0% of topical corticosteroid prescriptions, whereas 56.3% were lowpotency and 38.7% were medium-potency agents. Of the 696,285 mentions of clotrimazole-betamethasone dipropionate, 56.4% (389,920) were for children aged newborn to 4 years; diagnoses were erythematodesquamatous dermatoses, diaper rash, tinea, well-baby visit, and candidiasis. In contrast, for dermatologists nationwide, no drug mention existed for this combination agent for children aged newborn to 4 years over the 5-year study period. Our results show that clotrimazole-betamethasone dipropionate is prescribed inappropriately by pediatricians, especially in the treatment of young children. Pediatricians rarely use high-potency topical corticosteroid agents, but most of their use of clotrimazolebetamethasone dipropionate is in the youngest children, in whom such corticosteroid use is least appropriate. This prescription pattern suggests that some pediatricians may be unaware that clotrimazole-betamethasone dipropionate has a high-potency corticosteroid component.

References (16)

There are more references available in the full text version of this article.

Cited by (25)

  • Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams

    2017, Journal of Pediatrics
    Citation Excerpt :

    We recommend against the use of combination antifungal/corticosteroid creams because of the greater cost, lower efficacy, and greater risk of adverse effects. Patients with the diagnosis of a cutaneous fungal infection who complain of intense pruritus in association with an infection-induced dermatitis are best treated by simultaneous application of a low- or medium-potency topical corticosteroid for a limited period of 7-10 days, along with a topical antifungal agent that will be continued until clinical findings resolve.13 For diaper dermatitis with confirmed secondary fungal infection, we suggest using a single topical antifungal agent in combination with a barrier cream.

  • Diagnosis and Management of Diaper Dermatitis

    2014, Pediatric Clinics of North America
    Citation Excerpt :

    Infants also have a relatively higher body surface area-to-volume ratio, making them more prone to absorption of topical medications. Combination products that contain clotrimazole and betamethasone dipropionate or nystatin and triamcinolone acetonide should be avoided and the former is specifically labeled by the FDA not to be used in patients younger than 17 years or in pediatric patients with diaper dermatitis.30 Topical inhibitors of calcineurin were developed for the treatment of mild to moderate (pimecrolimus) or moderate to severe (tacrolimus) atopic dermatitis as a second-line treatment.

  • What's Your Diagnosis? Nine-year-old Girl with a Pubic Rash Gone Incognito

    2006, Journal of Pediatric and Adolescent Gynecology
  • Adverse effects of topical glucocorticosteroids

    2006, Journal of the American Academy of Dermatology
    Citation Excerpt :

    In particular, fixed combinations of betamethasone and clotrimazole were frequently prescribed.108 As expected, pediatricians preferred low-potency (56.3%) over high-potency (5%) or medium-potency derivatives (28.7%).107,109 In addition, these combination products tend to be used for diaper rash and are therefore occluded by the diaper.

  • Mixture of honey, beeswax and olive oil inhibits growth of Staphylococcus aureus and Candida albicans

    2005, Archives of Medical Research
    Citation Excerpt :

    Beeswax was used as vehicle for preparation of the ointment. Furthermore, olive oil and beeswax application could have beneficial influence on skin lesions (2,16,22). In addition, the contents of the mixture might have a synergistic effect that needs further investigation.

  • Phototherapy utilization for psoriasis is declining in the United States

    2002, Journal of the American Academy of Dermatology
View all citing articles on Scopus
View full text